Get startedLog in
    Picture of Kalvista Pharmaceuticals logo

    KALV — Kalvista Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapMomentum Trap
    All News

    Brief: Kalvista Pharmaceuticals Enters Into Licensing Agreement With Kaken Pharmaceutical To Commercialize Sebetralstat For HAE In Japan

    Picture of Kalvista Pharmaceuticals logoKalvista Pharmaceuticals
    08/04/2025 11:31
    April 8 (Reuters) - Kalvista Pharmaceuticals Inc KALV.O:

KALVISTA PHARMACEUTICALS ENTERS INTO LICENSING AGREEMENT WITH KAKEN PHARMACEUTICAL TO COMMERCIALIZE SEBETRALSTAT FOR HAE IN JAPAN

KALVISTA PHARMACEUTICALS INC - ENTERS LICENSING AGREEMENT WITH KAKEN FOR SEBETRALSTAT IN JAPAN

KALVISTA PHARMACEUTICALS INC - UP TO $24 MILLION IN UPFRONT AND MILESTONE PAYMENTS, PLUS ROYALTIES

Source text: ID:nBw5fHhhTa

Further company coverage: KALV.O

 (((( Reuters.briefs@thomsonreuters.com ;));))

    Recent news on Kalvista Pharmaceuticals

    See all news